Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 29)*
M.D.C. HOLDINGS, INC.
(Name of Issuer)
Common Stock, $0.01 Per Share
(Title of Class of Securities)
552676 108
(CUSIP Number)
David D. Mandarich, 4350 S. Monaco St., Suite 500, Denver, CO 80237
(303) 773-1100
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
November 10, 2022
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (e), 13d-1(f) or 13d-1(g), check the following box [ ].
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 4
CUSIP NO. 552676 108
| (1) | NAME OF REPORTING PERSON | ||||||||||||||||
| David D. Mandarich | |||||||||||||||||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [ ] | |||||||||||||||
| Not Applicable | (b) [ ] | ||||||||||||||||
| (3) | SEC USE ONLY | ||||||||||||||||
| (4) | SOURCE OF FUNDS | ||||||||||||||||
| OO | |||||||||||||||||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | [ ] | |||||||||||||||
| Not Applicable | |||||||||||||||||
| (6) | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||||||||||||||
| United States of America | |||||||||||||||||
| Number of Shares Beneficially Owned by Each Reporting Person with | (7) | SOLE VOTING POWER | |||||||||||||||
| 5,642,943 | |||||||||||||||||
| (8) | SHARED VOTING POWER | ||||||||||||||||
| 0 | |||||||||||||||||
| (9) | SOLE DISPOSITIVE POWER | ||||||||||||||||
| 5,642,943 | |||||||||||||||||
| (10) | SHARED DISPOSITIVE POWER | ||||||||||||||||
| 0 | |||||||||||||||||
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||||||||||||||
| 5,642,943 | |||||||||||||||||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES | [ ] | |||||||||||||||
| Not Applicable | |||||||||||||||||
| (13) | PERCENT OF CLASS REPRESENTED BY THE AMOUNT IN ROW (11) | ||||||||||||||||
| 7.9% | |||||||||||||||||
| (14) | TYPE OF REPORTING PERSON | ||||||||||||||||
| IN | |||||||||||||||||
Page 2 of 4
EXPLANATORY NOTE: This is a voluntary filing to reflect changes in Reporting Person’s holdings over the prior year. This amendment amends and supplements only information that has changed since the filing of the previous amendment. | ||||||||||||||
The Reporting Person, David D. Mandarich, hereby amends his Schedule 13D relating to the Common Stock, par value $0.01, of M.D.C. Holdings, Inc. (the “Company”).
Item 5. Interest in Securities of the Issuer
(a)Mr. Mandarich beneficially owns an aggregate of 5,642,943 shares of Common Stock, representing approximately 7.9% of the outstanding Common Stock of the Company. The ownership percentage set forth above is based upon 71,264,182 shares of Common Stock of the Company outstanding, as reported in the Company’s Form 10-Q filed on October 27, 2022, plus an additional 593,280 shares which Mr. Mandarich has the right to acquire upon the exercise of stock options that are fully vested.
(b)Mr. Mandarich has the:
(i)Sole power to vote or direct the vote of 5,642,943 shares. This consists of 5,049,663 shares that he directly owns (including unvested restricted stock granted under the Company’s equity incentive plans) and 593,280 shares issuable upon the exercise of stock options granted under the Company's equity incentive plans.
(ii)Shared power to vote or direct the vote of -0- shares.
(iii)Sole power to dispose or direct the disposition of 5,642,943 shares. This consists of the shares described in response to Item 5(b)(i) above.
(iv)Shared power to dispose or direct the disposition of -0- shares.
(c)On November 10, 2022, Mr. Mandarich exercised an option for 1,322,697 shares and sold 866,029 shares that day. On November 11, 2022, Mr. Mandarich sold 213,971 shares.
(d)None.
(e)Not applicable.
Page 3 of 4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: November 14, 2022
Signature: /s/ David D. Mandarich
Name: David D. Mandarich
Page 4 of 4